查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1314779

脊椎生物製品市场：副产品（移植骨替代物、细胞基质、同种异体脊椎移植物），依最终使用者（门诊手术中心、医院）-2023-2030 年全球预测

Spine Biologics Market by Product (Bone Graft Substitutes, Cell-Base Matrix, Spinal Allografts), End-User (Ambulatory Surgical Centers, Hospitals) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球脊椎生物製剂市场将大幅成长，达50.9374亿美元，年复合成长率为17.08%，2030年将达到153.804亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球脊椎生物製剂市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 脊椎生物製剂的全球市场规模与预测为何？

2.在预测期内，COVID-19 对全球脊椎生物製品市场的阻碍因素和影响为何？

3. 在预测期内，全球脊椎生物製品市场需要投资哪些产品/细分市场/应用/领域？

4.全球脊椎生物製剂市场的竞争策略是什么？

5. 全球脊椎生物製剂市场的技术趋势和法律规范是什么？

6. 全球脊椎生物製剂市场主要供应商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入全球脊椎生物製剂市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 对微创手术的需求和偏好不断增长
      • 脊髓退化疾病的发生率和治疗率不断增加
      • 骨移植手术的快速进展
    • 抑制因素
      • 这些程序非常昂贵
    • 机会
      • 生物材料的持续进步改善脊椎疾病的治疗
      • 政府资助扩大脊椎生物学研究
    • 任务
      • 产品召回问题
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章脊椎生物製剂市场：副产品

  • 骨移植替代物
    • 骨形成蛋白
    • 合成骨移植物
  • 基于细胞的矩阵
  • 同种异体脊椎移植物
    • 去矿骨基质
    • 机械加工同种异体骨

第7章脊椎生物製品市场：依最终用户分类

  • 门诊手术中心
  • 医院

第8章美洲脊椎生物製品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第9章亚太脊椎生物製品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲脊椎生物製品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第11章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第12章上市公司名单

第13章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-A86604082636

The Global Spine Biologics Market is forecasted to grow significantly, with a projected USD 5,093.74 million in 2023 at a CAGR of 17.08% and expected to reach a staggering USD 15,380.40 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Spine Biologics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Spine Biologics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Bone Graft Substitutes, Cell-Base Matrix, and Spinal Allografts. The Bone Graft Substitutes is further studied across Bone Morphogenetic Proteins and Synthetic Bone Grafts. The Spinal Allografts is further studied across Demineralized Bone Matrix and Machined Bones Allograft. The Bone Graft Substitutes is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals. The Ambulatory Surgical Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Spine Biologics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Spine Biologics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spine Biologics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spine Biologics Market?

4. What is the competitive strategic window for opportunities in the Global Spine Biologics Market?

5. What are the technology trends and regulatory frameworks in the Global Spine Biologics Market?

6. What is the market share of the leading vendors in the Global Spine Biologics Market?

7. What modes and strategic moves are considered suitable for entering the Global Spine Biologics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Spine Biologics Market, by Product, 2022 vs 2030
  • 4.3. Spine Biologics Market, by End-User, 2022 vs 2030
  • 4.4. Spine Biologics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand and preference for minimally invasive procedures
      • 5.1.1.2. Rising incidence of degenerative spine disorders and rise in treatment rates
      • 5.1.1.3. Proliferation in advancements of bone grafting procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Extremely high cost of these procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in biomaterials improving the treatment of spine disorders
      • 5.1.3.2. Government funding to expand spine biologics research
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to product recalls
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Spine Biologics Market, by Product

  • 6.1. Introduction
  • 6.2. Bone Graft Substitutes
    • 6.2.1. Bone Morphogenetic Proteins
    • 6.2.2. Synthetic Bone Grafts
  • 6.3. Cell-Base Matrix
  • 6.4. Spinal Allografts
    • 6.4.1. Demineralized Bone Matrix
    • 6.4.2. Machined Bones Allograft

7. Spine Biologics Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals

8. Americas Spine Biologics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Spine Biologics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Spine Biologics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. SPINE BIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. SPINE BIOLOGICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. SPINE BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 6. SPINE BIOLOGICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. SPINE BIOLOGICS MARKET DYNAMICS
  • FIGURE 8. SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. SPINE BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. SPINE BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. SPINE BIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. SPINE BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 6. SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. SPINE BIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. SPINE BIOLOGICS MARKET SIZE, BY CELL-BASE MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 11. SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. SPINE BIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. SPINE BIOLOGICS MARKET SIZE, BY MACHINED BONES ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. SPINE BIOLOGICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. THAILAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. DENMARK SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. DENMARK SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EGYPT SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EGYPT SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. FINLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. FINLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FRANCE SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. FRANCE SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. GERMANY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. GERMANY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ITALY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. ITALY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NORWAY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NORWAY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. POLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. POLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. QATAR SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. QATAR SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SPAIN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SPAIN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. TURKEY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. TURKEY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. SPINE BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 186. SPINE BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 187. SPINE BIOLOGICS MARKET LICENSE & PRICING